期刊文献+

扶正防癌方治疗晚期非小细胞肺癌的疗效观察 被引量:4

Clinical Observation of Fuzheng Anti-cancer Prescription (扶正防癌方) In The Treatment of Advanced Non-small Cell Lung Cancer
下载PDF
导出
摘要 目的:探讨具有补益脾肾作用的扶正防癌方治疗脾肾两虚型晚期非小细胞肺癌(SCLC)的疗效及对患者外周血调节性T细胞(Treg细胞)的影响。方法:将46例晚期NSCLC患者,随机分为治疗组和对照组,每组23例。比较两组外周血液中Treg细胞百分占比和细胞因子含量,比较两组实体瘤近期疗效,体质量及Karnofsky评分、生活质量QOL-C30评分、中医证候积分。结果:治疗组治疗后外周血Treg细胞百分比、细胞因子含量低于治疗前,差异均有统计学意义(P<0.05);对照组治疗前后比较,差异无统计学意义(P>0.05)。治疗后两组体质量及Karnofsky评分、中医证候积分、生活质量QOL-C30评分均升高,且治疗组高于对照组,差异均有统计学意义(P<0.05);两组实体瘤近期疗效比较,差异无统计学意义(P>0.05)。结论:扶正防癌方能调节Treg细胞及细胞因子,改善临床症状和生活质量,是晚期NSCLC患者可选择的有效的临床治疗方法之一。 Objective: To investigate the therapeutic effect of Fuzheng Anti-cancer Prescription on advanced non-small cell lung cancer(SCLC) with deficiency of both spleen and kidney and its effect on regulatory Treg cells in peripheral blood of patients. Methods: A total of 46 patients with advanced NSCLC were randomly divided into the treatment group and the control group, 23 patients in each group. The percentage ratio and cytokine content of Treg cells in peripheral blood, the short-term curative effect of solid tumors, the physical quality and Karnofsky score, QOL-C30 score and TCM syndromes score were compared between the two groups.Results: The percentage of peripheral blood Treg cells and cytokine content were lower in the treatment group than before(P〈0.05). There was no significant difference between before and after treatment in the control group(P〈0.05). After treatment, both groups had higher physical quality, Karnofsky score, TCM score, and QOLC30 score, and the treatment group was higher than the control group. The difference was statistically significant(P〈0.05). There was no significant difference in the short-term curative effect of solid tumors between two groups(P〈0.05). Conclusion: Fuzheng Anti-cancer Prescription can regulate Treg cells and cytokines, improve clinical symptoms and quality of life, is one of the effective clinical treatment options for advanced NSCLC patients.
作者 刘声 吴洁 孙书贤 关丽 LIU Sheng;WU Jie;SUN Shu-xian;GUAN Li(Beijing Hospital of Traditional Chinese Medicine,Capital Medical University,Beijing 100010,China;Guang'anmen Hospital,Chinese Academy of Chinese Medicine Sciences,Beijing 100053,China)
出处 《中医药导报》 2018年第17期36-39,共4页 Guiding Journal of Traditional Chinese Medicine and Pharmacy
基金 北京市卫生系统高层次卫生技术人才培养项目
关键词 晚期非小细胞肺癌 补益脾肾法 扶正防癌方 临床观察 advanced non-small cell lung cancer supplemental spleen and kidney method Fuzheng Anti-cancer Prescription clinical observation
  • 相关文献

参考文献2

二级参考文献23

  • 1万崇华,陈明清,张灿珍,汤学良,孟琼,张晓磬.癌症患者生命质量测定量表EORTC QLQ-C30中文版评介[J].实用肿瘤杂志,2005,20(4):353-355. 被引量:1283
  • 2李海军,王辉,方全华,张国庆.康莱特注射液诱导肝癌细胞凋亡及其对凋亡蛋白procaspase-3和caspase-9表达的影响[J].肿瘤,2010,30(9):740-743. 被引量:18
  • 3梁铁军,秦成勇,谭艳蓉,蒋莹,赵小茜.康莱特抑制肝癌细胞HepG2增殖的实验研究[J].中国肿瘤临床,2006,33(13):743-746. 被引量:15
  • 4张爱琴,马胜林,孙在典,包素珍.康莱特注射液对Lewis肺癌小鼠免疫功能的影响[J].浙江中西医结合杂志,2007,17(4):199-200. 被引量:25
  • 5Peter G.. Staging manual in thoracic onocology [ M]. 7th ed. USA : Orange Park ,2009:61.
  • 6Therasse P, Arbuck SG, Eisenhauer EA, et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada [ J]. J Natl Cancer lnst, 2000,92 ( 3 ) : 205 - 216.
  • 7Hung R, Krebs P, Coups E J, et al. Fatigue and functional impairment in early-stage non-small cell lung cancer survivors [ J ]. J Pain Symptom Manage, 2011,41 ( 2 ): 426 - 435.
  • 8Mohan A, Singh P, Singh S, et al. Quality of life in lung cancer patients: impact of baseline clinical profile and respiratory status [ J]. Eur J Cancer Care,2007,16 (3) :268 -276.
  • 9Grande GE, Farquhar MC, Barclay SI, et al. Quality of life measures (EORTC QLQ-C30 and SF-36 ) as predictors of survival in palliative colorectal and lung cancer patients [ J ]. Palliat Support Care, 2009,7 ( 3 ) : 289 - 297.
  • 10Kenny PM, King MT, Viney RC, et al. Quality of life and survival in the 2 years after surgery for non-small cell lung cancer [J].J Clin 0ncol,2008,26 ( 2 ) : 233 - 241.

共引文献42

同被引文献73

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部